Bavarian Nordic A/S announced that Laurence de Moerlooze has taken up the position as Executive Vice President and Chief Medical Officer (CMO) of Bavarian Nordic, a role she was appointed in January 2020. Dr. De Moerlooze joins Bavarian Nordic from Takeda Vaccines, where she has served since 2017 as Vice President and Global Program Lead for vaccines against Zika virus and Norovirus. Prior to joining Takeda, she worked at GlaxoSmithKline (GSK) for more than 15 years, holding various leading roles in medical affairs and vaccine development working with numerous life-saving vaccines including Rabipur/Rabavert and Encepur.